CRH plc (NYSE: CRH) — The Compounder After the Re-Rating: Now You Pay for Execution, Not the Cheap Ticket

Independent equity research — for general information only Report date: 2026-06-14 · Price reference: $106.48 (2026-06-12) · CIK 0000849395 · FY ends 31 December · Reporting currency USD, US GAAP

⚡ Claude’s Take

This block is the author’s own subjective opinion and general information only — it is not investment advice and not a recommendation to buy or sell any security. It is fenced off deliberately: the analysis that follows takes no position and carries no price target, and only this clearly-labeled block expresses a view.

Verdict: HOLD a high-quality compounder at a fair-but-no-longer-cheap price — accumulate on weakness, do not chase. Not a short. Fair-value zone ≈ $105–125 (≈10–11x 2026E adjusted EBITDA of $8.1–8.5B, ≈18–20x 2026E EPS of $5.60–6.05). The price you actually want is sub-$95 (≈9–9.5x EBITDA), the zone the recent ~25% drawdown briefly flirted with.

CRH is the genuine article: the world’s largest building-materials company, the #1 US aggregates owner by reserves (~23.8bn tons — more stone in the ground than anyone), wrapped in a vertically integrated “connected” model that wins whole infrastructure jobs. The aggregates moat is among the most durable in all of industrials — a local monopoly protected by geology and a permitting regime that makes new supply nearly impossible to build. That is real, and it shows up in 25 years of through-cycle pricing power. But the easy money has been made. The entire bull thesis of 2023 — “European-listed conglomerate discount closes when it lists on the NYSE and gets valued like Vulcan and Martin Marietta” — has already played out: the stock tripled off its 2022 lows, P/E went from 7x to ~19x, and it now sits at the 87th percentile of its own ten-year valuation range (91st on price/book, 93rd on price/sales). What remains is a still-real but partly-deserved ~25–35% EV/EBITDA discount to VMC/MLM (deserved because CRH’s blended ~20% EBITDA margin is structurally below their ~29–34% pure-aggregates margins) and a business that must now grow into its multiple rather than re-rate up to it.

The framing is quality-compounder-at-a-price, not falling knife and not bargain. The factor tape agrees: high beta (~1.3), quality and dividend tilts, modest positive momentum that rolled over into a -28% six-month drawdown as the market shifted from “re-rating winner” to “show-me” ahead of the September-2026 IIJA reauthorization cliff and a soft residential cycle. My single hesitation on the quality of the compounding is that adjusted ROIC fell 130bps to 12.1% in 2025 as a swelling, goodwill-heavy ($13.1bn) balance sheet outran operating income — the M&A machine may be running slightly ahead of its returns. Conviction: medium. Bullish flip: a multi-year IIJA reauthorization at a meaningful step-up and ROIC re-accelerating back above 13% — that would justify chasing. Bearish flip: a hard funding cliff / short-term continuing resolution and ROIC bleeding below 10% as deals keep diluting returns — that would make the peer discount fully deserved and the stock dead money. Tag: you missed the cheap ticket; this is now a toll you pay for a toll road.

1. Executive Summary

CRH plc is the largest building-materials company in the world (FY2025 revenue $37.4bn, adjusted EBITDA $7.7bn, 20.5% margin) and the dominant North American producer of aggregates, asphalt and “road solutions,” with ~75% of net income and 71% of adjusted EBITDA generated in North America. It is organized into three reporting segments — Americas Materials Solutions (45% of revenue, 52% of EBITDA, 23.5% margin), Americas Building Solutions (19%/19%, 20.7%), and International Solutions (36%/29%, 16.6%, primarily Europe and Australia).

The investment story has two acts. Act One (2022–2024): the re-rating. A multi-decade transformation into a North-America-centric industrial culminated in the September 2023 move of CRH’s primary listing to the NYSE and S&P 500 inclusion. The market repriced the stock from a ~7x P/E “European conglomerate” toward a US-industrial multiple; enterprise value rose from ~$34bn (2022) to ~$89bn (2025), the P/E went 7x → 19x, and total return compounded at ~32% annually over three years. Act Two (now): the compounding test. With the discount to US peers Vulcan (VMC) and Martin Marietta (MLM) substantially closed and the stock at the 87th percentile of its own historical valuation, future returns must come from earnings growth and capital deployment, not further multiple expansion.

The business quality is high and the moat is real. Aggregates is a textbook local-monopoly business — a low-value, high-weight product (~$15–20/ton) that is uneconomic to ship beyond ~30–50 miles, combined with permitting and reserve-scarcity barriers that make new competing supply nearly impossible to build. CRH owns the deepest reserve base in the US and adds a vertically integrated model (aggregates → cement → asphalt → ready-mix → paving and products) that competitors cannot easily replicate. In Greenwald’s taxonomy this is a cost/supply advantage reinforced by local economies of scale and customer captivity — the most durable archetype. The financial signature is 25 years of mid-single-digit aggregates price growth through cycles and a gross margin that has risen from 33% to 36% since 2020.

The principal tensions are three. (1) Valuation: the cheap entry point is gone; CRH is fairly-to-fully valued on its own history even if it looks cheap versus pure-play peers, and that peer discount is partly justified by a lower-margin, more diversified mix. (2) Returns trend: adjusted ROIC declined 130bps to 12.1% in 2025 on a balance sheet now carrying $13.1bn of goodwill (22% of assets) — the M&A roll-up’s returns are thinning at the margin even as absolute growth continues. (3) Cyclical/macro overhang: ~half of IIJA construction dollars are still to be spent (a funded multi-year tailwind), but authorizations expire 30 September 2026 and a soft US residential new-build market caps one demand leg.

Capital allocation is disciplined and shareholder-friendly — a programmatic ~$3–5bn/year bolt-on M&A engine, a 15% reduction in share count since 2020, six-percent dividend growth, and returns-aware incentive metrics (RONA, relative TSR, cash flow). The skeptical counterpoint is the absence of goodwill impairments despite the declining ROIC and an unverifiable “2–2.5x entry-multiple reduction via synergies” claim. Insider activity is neutral-to-slightly-positive (three small director open-market buys; no executive buying; one modest COO sale). The leadership has just turned over: Albert Manifold (CEO since 2014) handed to Jim Mintern on 1 January 2025, with Nancy Buese (ex-Newmont/MPLX) as CFO from May 2025.

This memo takes no position and sets no price target. It frames valuation as embedded expectations: at ~10.4x forward EV/EBITDA and ~18x forward earnings, the market is underwriting continued high-single-digit EBITDA growth and successful capital deployment — neither heroic versus peers nor cheap versus CRH’s own past.

2. Business Overview

What CRH does. CRH manufactures and sells the physical inputs of construction and the integrated solutions built from them. At the base of the value chain it produces aggregates (crushed stone, sand and gravel — 380.7m tons sold in 2025), cement and cementitious materials (59.0m tons), asphalt (62.8m tons) and ready-mixed concrete (39.5m cubic yards). On top of that materials base it layers road/paving construction services, building and infrastructure products (precast concrete, water-management structures, utility infrastructure), and outdoor-living products (hardscapes, masonry). It is, in the company’s own framing, a “connected portfolio” spanning the construction value chain rather than a single-product commodity producer.

How it makes money. Revenue is overwhelmingly transactional rather than recurring/contractual: CRH sells materials and services into construction projects, with demand split across public infrastructure (roads, highways, bridges, water — the largest and most stable end-market), non-residential/commercial (now boosted by data centers and reshored manufacturing), and residential (new-build, weak; repair-and-remodel, resilient). There is no subscription or recurring-revenue base; the “stickiness” comes not from contracts but from the structural impossibility of a customer sourcing aggregates from anywhere other than the nearest quarry — a geographic lock-in rather than a contractual one. Pricing is set locally, market-by-market, and is the principal margin lever.

Segment structure (FY2025).

• Americas Materials Solutions is the profit engine — the vertically integrated US aggregates/cement/asphalt/ready-mix and paving business, the #1 player in US aggregates and road solutions, and the highest-margin segment at 23.5%. This is where the moat lives.
• Americas Building Solutions is the higher-value-added North American products business — water/utility infrastructure structures, outdoor living, building products. Lower cyclicality in parts (infrastructure, R&R) but more competitive (manufactured products are shippable, unlike aggregates).
• International Solutions is Europe (Western and Central/Eastern) plus Australia (post-Adbri). Lower-margin (16.6%) and lower-growth, but it grew adjusted EBITDA +23% in 2025 on the Adbri consolidation and European pricing discipline — a reminder the “100% North America” caricature is incomplete.

The “connected portfolio” — how the integration actually pays. CRH’s central operating claim is that owning the whole chain is worth more than the sum of the parts, and the mechanism is concrete rather than rhetorical. First, pull-through demand: because CRH supplies aggregates and cementitious materials into its own downstream products and paving jobs (over 80% of its water-business products consume CRH aggregates/cementitious; over 85% of roads need water-management systems), it captures margin at multiple stages of a single project and deepens customer relationships. Second, integrated bidding: at scale (4,000 locations) CRH can bid an entire highway reconstruction — aggregates, asphalt, paving, drainage structures — as one supplier, which both wins work and raises the share of project wallet. Third, the winter-fill advantage in Road Solutions: CRH stores roughly half its annual liquid-asphalt requirement off-season, capacity built over decades, giving it procurement cost-certainty and security of supply through the short paving season — a genuine, hard-to-replicate operating edge management calls out explicitly. Fourth, lower capital intensity and a more variable cost base than a single-stage producer, which improves flexibility through downturns. The trade-off, quantified later, is that this breadth lowers the blended margin relative to a pure-aggregates peer — integration buys resilience and wallet share at the cost of mix-down margin.

Geographic profile. ~75% of net income / 71% of adjusted EBITDA from North America; the remainder from Europe and Australia. The strategic direction of travel for two decades has been toward North America (US entry 1978; Lafarge-Holcim asset acquisition 2015; Ash Grove cement 2018; the 2023 NYSE listing), funded partly by divesting European and non-core businesses (Oldcastle BuildingEnvelope 2022; European Lime 2024; Lawn & Garden, Construction Accessories, MoistureShield 2026).

Verdict: A real, tangible, essential-products business with a dominant position in the best node of its industry, diversified across end-markets and geographies, but with transactional (not recurring) revenue and meaningful cyclicality. High-quality for what it is — a building-materials company — and the segment mix confirms the profit center is the moated US materials business.

3. Industry Dynamics

The aggregates node is one of the best industries in all of industrials, and it anchors the thesis. The economics are driven by physics. Crushed stone, sand and gravel sell ex-quarry for roughly $15–20 per ton — a low-value, high-weight commodity. Freight costs roughly $0.15–0.30 per ton-mile, so transporting the product more than ~20–30 miles can double the landed cost, and beyond ~30–50 miles it becomes uneconomic to sell at all. Delivery can represent 30–70% of a contractor’s final material cost. The consequence is that every quarry is a de-facto local monopoly or tight oligopoly: demand within a radius can only be served from quarries within that radius, and a distant competitor with a lower pit price still loses on landed cost.

What makes this durable rather than merely favorable is the barrier to new supply. New quarries are extraordinarily hard to permit — it can take over a decade to bring one online, community/zoning (“NIMBY”) opposition is intensifying, and reserves near growing urban demand centers are scarce and depleting. A well-capitalized entrant cannot simply dig a new pit next to an incumbent’s; the binding constraint is a permit and a geological endowment, not money. This is the rare industry where Marathon’s capital-cycle mean-reversion mechanism is structurally broken: high returns do not attract offsetting supply, because supply cannot be permitted. Consolidation (Quikrete’s $11.5bn purchase of Summit Materials in 2025; CRH’s and peers’ continuous bolt-ons) is concentrating an already-tight supply base.

The financial proof of the moat is pricing power through the cycle. US aggregates prices have compounded up at mid-single-digit rates for ~25 years, rising even in volume-down years — including 2008–09 and the 2020 COVID air-pocket. Volume is cyclical; price is not. CRH’s 2025 aggregates volumes rose ~6% with price up ~3% (mix-affected; mix-adjusted price was higher), and management guides to low-single-digit volume and mid-single-digit pricing for 2026.

Cement and downstream are good-not-great. Cement is more capital- and energy-intensive, more contestable (it can be shipped/imported far further than aggregates), and carbon-regulated in Europe (EU ETS carbon price >$80/tonne; CBAM border levy phasing in from 2026). Downstream products and paving services are competitive, lower-margin businesses. This mix is precisely why CRH’s blended EBITDA margin (~20%) sits well below the ~29–34% of pure-play aggregates peers — and why a valuation discount to those peers is partly deserved rather than purely a listing artifact.

The cement node deserves elaboration because it is both a strength and the chief quality dilutant. Strength: in a vertically integrated model, captive cement and cementitious supply (CRH produces 59m tons/year of cementitious material and ran kilns at 72% utilization in 2025) feeds CRH’s own ready-mix and products operations, smoothing input costs and improving security of supply — the Eco Material acquisition (fly-ash / supplementary cementitious materials, $2.1bn in 2025) deepens this and is partly a decarbonization hedge (SCMs reduce the clinker fraction and thus the carbon intensity of concrete). Dilutant: cement is a globally traded, energy-hungry commodity whose pricing — unlike aggregates — can be undercut by imports at coastal markets, and whose European production carries a real and rising carbon cost. EU ETS allowances (>$80/tonne, free allocations phasing out) plus the CBAM import levy (financial obligations beginning 2026, full phase-in by 2034) raise European cement costs; CBAM at least levels the field against carbon-leakage imports. The net financial materiality: meaningful for CRH’s European cement (a minority of group EBITDA), largely immaterial for the ~75% North American business where no comparable federal carbon price exists. It is a manageable European cost headwind, not a thesis-breaker.

The capital cycle, in Marathon’s terms. The single most important structural fact about aggregates is that the mechanism which destroys most high-return industries — high returns attract new capital, new capacity floods in, returns mean-revert — does not operate here. You cannot permit a new quarry next to an incumbent’s; capital, however abundant, cannot manufacture a permit or a geological deposit near urban demand. So CRH and its peers can earn rising returns for decades without inviting the supply response that would normally compete those returns away. Consolidation reinforces this: each bolt-on removes an independent operator and tightens local pricing discipline. This is the rare industrials setting where Marathon’s framework flashes green on the supply side — capital is starved, not abundant, exactly where incumbents want it starved. The caveat is that this clean logic applies in full only to aggregates; cement is more contestable and more capital-attracting, which is one more reason the pure-aggregates peers earn the premium multiple.

Demand backdrop (2026). Three pillars:

1. Public infrastructure (the anchor). The 2021 IIJA ($1.2tn; ~$550bn new) drove a step-change in federal highway funding. As of early 2026, ~73% of DOT funding is obligated but only ~43% is actually spent on construction — i.e., roughly half the construction dollars are still ahead, a multi-year, already-funded tailwind. State DOT budgets are at records (2026 budgets ~+6%). The overhang: IIJA authorizations expire 30 September 2026; a multi-year reauthorization (bill H.R. 8870 introduced May 2026) is in play but faces a ~$166bn Highway Trust Fund revenue gap. This is the single largest medium-term swing factor for sector volumes.
2. Reindustrialization / non-residential. Data-center and AI-driven construction, CHIPS-Act fabs, and reshored manufacturing are aggregates- and cement-intensive megaprojects. CRH cited supplying 1.2m tons of aggregates to a single Michigan data center in Q1 2026 alone, plus a Boise chip plant and I-95 widening in South Carolina.
3. Residential (the soft leg). US housing starts (~1.47m SAAR, April 2026) are constrained by affordability; new-build is subdued. Repair-and-remodel is structurally more resilient (aging housing stock, the “lock-in” effect of low legacy mortgages). CRH frames the resi weakness as cyclical, not structural.

Verdict: structurally good industry, best-in-class at the aggregates node. Aggregates is a permit-protected local monopoly with broken mean-reversion — among the most attractive industry structures available to a public-market investor. Cement and downstream dilute that quality. The net is a clearly good industry whose principal risks are macro/cyclical (the IIJA cliff, the resi cycle, European cement carbon costs) rather than structural erosion of the moat.

4. Competitive Position

The moat, named precisely. CRH’s durable advantage is a cost/supply advantage (privileged access to irreplaceable, permit-protected aggregates reserves near demand) reinforced by local economies of scale and customer captivity — the strongest archetype in the Greenwald framework. It is durable because the binding constraint on a challenger is geology plus a permit, neither of which capital can manufacture. CRH owns the deepest reserve base in the US — ~23.8bn tons of aggregates reserves across 1,334 mining properties (27,519m tons of reserves plus 12,968m tons of resources in the 10-K’s formal mineral-reserve disclosure) — equivalent to ~60–70+ years at current extraction rates, “more stone in the ground than anyone else in the industry.”

The second layer: vertical integration / the “connected portfolio.” CRH is unusual in spanning aggregates → cement → asphalt → ready-mix → paving services → products under one roof. This lets it bid integrated highway and infrastructure jobs end-to-end, capture more of the project wallet, and drive “pull-through” demand for its own essential materials (over 80% of its water-business products consume CRH aggregates/cementitious materials; over 85% of roads need water-management systems). It also lowers capital intensity and increases the variable-cost share, giving the business more flexibility through downturns. This integration is genuinely hard to replicate at CRH’s scale (4,000 locations) and is the qualitative differentiator versus the pure-plays.

Direct comparison to the pure-play peers (VMC, MLM).

Two readings follow. First, CRH is bigger and arguably better-positioned on the asset base — more revenue, more aggregates volume, the deepest reserves, and (notably) a higher return on invested capital than either pure-play, whose ROICs are currently depressed by their own recent large acquisitions. Second, CRH’s blended margin is structurally lower because VMC and MLM are deliberately concentrated in the single highest-margin node (VMC’s explicit “Aggregates First” strategy), whereas CRH’s mix includes lower-margin cement, downstream products and international operations. The market therefore rationally awards CRH a lower EV/EBITDA multiple — the ~25–35% discount is part mispricing and part deserved. The bull’s “re-rate to peer parity” case has limits: CRH should trade at a discount to pure-aggregates margins; the open question is only how large a discount.

Pressure-testing the moat (Greenwald’s tests). Greenwald argues a genuine competitive advantage should show up as market-share stability and persistently high returns that resist competitive entry. Aggregates passes both. Share stability: local quarry positions essentially never change hands competitively — they change hands via acquisition, because the only way to enter a local market is to buy the incumbent (you cannot permit a competing pit). Return persistence: 25 years of through-cycle aggregates price increases, with prices rising even in volume-down recession years, is the financial fingerprint of an advantage that competitors cannot erode. The one place the moat is weaker is precisely where CRH differs from the pure-plays — cement (importable, contestable) and downstream products (manufactured, shippable, competitive). So the honest moat read is barbell-shaped: an extremely strong, durable advantage in the aggregates/local-materials core, a thinner advantage in cement and products, blended into a franchise that is clearly above-average but whose weakest segments are what keep its margins and multiple below the pure-aggregates peers. The vertical-integration edge is real but is an operating advantage (wallet share, cost smoothing, integrated bidding) more than a classic barrier-to-entry moat — a competitor could in principle assemble a similar integrated chain, it would just be expensive and slow.

Other competitors. The global cement/materials landscape includes Holcim (which spun off its entire North American business as Amrize (NYSE: AMRZ) in June 2025 — now a new direct US peer), Heidelberg Materials (#2 global cement), Cemex (deleveraging), Eagle Materials and Knife River (the 2023 MDU spin) among US names, plus Quikrete (private, now owner of Summit Materials). Consolidation is the dominant industry theme and CRH is one of its prime movers.

Verdict: durable competitive advantage, best-in-class at the asset level. CRH has the deepest moat in the industry by reserve base and the differentiation of vertical integration, and it earns a higher ROIC than the pure-plays. The advantage is durable. The caveat is purely about mix economics: the blended business is lower-margin than a pure-aggregates peer, which justifies a structural (if smaller-than-current) valuation discount rather than a premium.

5. Growth History and Forward Opportunities

The historical record is strong and reasonably high-quality. Revenue compounded from $25.9bn (2020) to $37.4bn (2025), ~7.6% annually, through a mix of organic volume/price and a relentless bolt-on M&A program. Crucially, the growth has been margin-accretive: gross margin rose from 33.1% to 36.1% and adjusted EBITDA margin from ~8% (a COVID-depressed 2020) to 20.5%, while net income attributable (continuing-operations basis) climbed $2,699m (2022) → $3,178m → $3,492m → $3,753m (2025). Management’s stated ten-year track record — 15% adjusted-EBITDA CAGR, ~110bps average annual margin expansion, 18% diluted-EPS CAGR, 19% TSR CAGR — is a management claim (treat as hypothesis), but the five-year financials I can verify are directionally consistent with it.

Organic vs. acquired. Growth is a deliberate blend: low-single-digit organic volume, mid-single-digit organic pricing, and ~$3–5bn/year of acquisitions that add both bolt-on density and occasional platform scale (Hunter cement $2.1bn in 2024; Eco Material $2.1bn in 2025). The pricing component is the highest-quality piece — it reflects the moat and carries near-100% incremental margin. The acquired component isvalue-accretive if the synergy claims hold (see Capital Allocation and the ROIC caveat).

Forward opportunities (the four “growth platforms”). Management frames growth around four connected platforms aligned to three secular megatrends (transportation, water, reindustrialization):

1. Aggregates — continued consolidation of a fragmented, permit-protected market; the core compounding engine.
2. Cementitious — including supplementary cementitious materials (SCMs/fly-ash) via the Eco Material acquisition, a decarbonization-and-supply play.
3. Road solutions — IIJA-funded paving and the unique “winter-fill” liquid-asphalt storage advantage (CRH stores ~half its annual liquid asphalt requirement off-season at scale — a genuine procurement and supply-security edge).
4. Water infrastructure — the most credible new leg: a ~$100bn+ annual US water ecosystem, fragmented, regulation-driven (1/3 of US water infrastructure >50 years old; ~4m lead service lines to replace; EPA funding via the IIJA), addressed through Axius Water ($700m, 2026, moving CRH up the value chain into treatment) and the VODA.ai AI-leak-detection partnership.

Management estimates ~$40bn of financial capacity over the next five years to deploy across these platforms — a large but unverified IR figure that signals the M&A engine will keep running.

The M&A engine, quantified. The reason CRH can grow faster than its end-markets is that it operates in structurally fragmented industries (aggregates, ready-mix, products, and especially water) where thousands of independent local operators exist to be bought. CRH runs this at industrial scale: ~38–40 deals and ~$3–5bn of acquisitions per year, the overwhelming majority being small bolt-ons that densify an existing local network (adding a quarry or plant that improves utilization, logistics and pricing in a market CRH already serves) rather than new-geography bets. The economics of a bolt-on are attractive when done right: a tuck-in bought at, say, 7–8x EBITDA can be worth 3–4x that to CRH once integrated, because the acquired volume flows through CRH’s existing fixed cost base and its supply is captively consumed downstream. Management’s claim of a “2–2.5x entry-multiple reduction” via synergies is the formalization of this, and the cited proof points (the Hunter cement plant “delivering synergies well ahead of expectations”; Eco Material “performing strongly”) are consistent with the margin expansion in the financials — though, as noted, the specific synergy figures are not independently verifiable. The risk in this model is precisely the one the ROIC trend is flagging: a roll-up that keeps deploying $4–5bn/year must keep finding deals at attractive post-synergy returns, and as CRH grows, the pool of needle-moving bolt-ons at the right price shrinks, pushing it toward larger, fuller-priced platform deals (Hunter, Eco Material, Axius) where the synergy math is harder. The 2025 ROIC dip is the first quantitative hint that the average incremental deal may be getting more expensive relative to its returns.

The water platform as the new growth vector. Of the four platforms, water is the one that could genuinely re-accelerate group growth over a decade. The setup is ideal for CRH’s playbook: a large (~$100bn+ annual US ecosystem; ASCE pegs 20-year needs at $625bn), highly fragmented, regulation- and necessity-driven market (a third of US water infrastructure is over 50 years old; ~4 million lead service lines remain; the US loses over 6 billion gallons/day to leaks) with stable public funding. CRH has spent decades building a transmission/structures position (Oldcastle Infrastructure) and is now moving up the value chain into treatment and water quality via Axius Water ($700m, 2026, acquired from KKR/XPV — adding nutrient-removal and wastewater-treatment IP) and the VODA.ai AI-leak-detection partnership. Water today is not yet a needle-mover against $37bn of group revenue, but it is the most credible new structural leg and a sensible use of CRH’s consolidation capability — provided it earns aggregates-like returns rather than diluting group ROIC as a lower-marginservices business (an open question).

Verdict: high-quality growth, with a caveat. The organic pricing growth is top-tier and moat-driven; the M&A growth is real and has been margin-accretive historically. The caveat is that the returns on incremental capital are thinning — growth is being bought with a swelling capital base, and the 2025 ROIC dip is the first quantitative hint that the volume of M&A may be slightly outrunning its quality. Growth is high-quality at the operating level; the watch item is capital efficiency.

6. Financial Quality

The five-year financial record at a glance.

*2022 reported diluted EPS of $5.05 includes the $1.19bn Oldcastle BuildingEnvelope discontinued-ops gain ($1.57/share); continuing-ops EPS was ~$3.53. Adjusted EBITDA figures pre-2025 are reconstructed (operating income + D&A) and approximate CRH’s reported adjusted basis.

The table tells the core story in numbers: revenue up ~28% over five years, margins expanding every year, EPS roughly doubling (on a clean continuing-ops basis), share count down ~13% — but net debt up ~4x (M&A-funded) and ROIC peaking in 2024 then slipping in 2025. The first four rows are the bull case; the last two are the bear case.

Margins and their trajectory. The standout positive is steady, structural margin expansion: gross margin 33.1% → 36.1% and EBITDA margin ~16.6% (2021) → 20.5% (2025, adjusted basis) over five years. This is the financial signature of pricing power outrunning input-cost inflation, plus operating leverage and acquisition synergies. (Data-quality note: some data aggregators report CRH’s “EBITDA” as ~14% because they equate EBITDA with EBIT for this filer — i.e., it omits the D&A add-back. CRH’s true/reported adjusted EBITDA is ~$7.7bn at a 20.5% margin; FY2025 D&A was $2,156m on operating income of $5,440m. All EBITDA figures in this memo use the correct, D&A-inclusive basis.)

Returns on capital — the central quality question. ROE is solid at ~14.9% (2025), and GAAP ROIC is ~10%. On CRH’s own “adjusted ROIC” basis, the figure is 12.1% in 2025 — but down 130bps from 13.4% in 2024. The decline is the key flag: average invested capital rose from ~$29.5bn to ~$35.9bn (acquisitions), faster than operating income grew. With ~$13.1bn of goodwill (22% of $58.3bn total assets) and ~$2bn of other intangibles, the tangible return picture is less flattering (price/tangible book ~7x). The spread of GAAP ROIC (~10%) over an estimated WACC (~8–9%) is positive but thin; on the adjusted basis it is more comfortable. The verdict on whether economics improve with scale is therefore nuanced: operating economics clearly improve (margins rise), but capital economics are flat-to-deteriorating at the margin because the growth is acquisition-led and goodwill-heavy.

Cash generation. Operating cash flow was $5.6bn in 2025; maintenance-plus-growth capex was $2.7bn (the 10-K does not split maintenance vs. growth, but management has historically implied roughly half is maintenance); simple FCF (CFO − capex) was ~$2.9bn, and FCF/share ~$4.33. Cash conversion is healthy (CFO consistently exceeds net income by ~1.5x, reflecting the heavy D&A of a capital-intensive business). This is a genuinely cash-generative business, though much of the cash is recycled into M&A rather than returned.

Balance sheet. Net debt (CRH basis, including finance leases) was $14.2bn at end-2025, ~1.8x adjusted EBITDA — a comfortable, investment-grade level (the debt rose from ~$5.4bn in 2023 as M&A accelerated, so the leverage trend is worth monitoring but is not yet a concern). Cash $4.1bn; current ratio 1.74. Pension liabilities are small ($248m). There is no balance-sheet fragility here.

Quality-of-earnings flags. (1) The single biggest distortion is FY2022, where reported net income of $3,889m was flattered by a $1,190m discontinued-operations gain on the Oldcastle BuildingEnvelope divestiture; continuing-operations net income was only $2,699m. Any growth trend that starts from 2022 reported net income overstates the trajectory — use the continuing-ops path. (2) Recurring but lumpy disposal gains ($66m/$237m/$235m in 2023/24/25) and a ~$258m non-operating gain in 2024 modestly flatter operating comparisons. (3) No material goodwill impairments ($40m/$161m/$357m in 2025/24/23) despite the aggressive deal pace and declining ROIC — either a sign of genuinely good underwriting or of lagging impairment recognition; worth watching. SBC is small and non-distorting (~$143m).

Verdict: high and improving operating quality; flat-to-thinning capital efficiency. Margins, cash generation and the balance sheet are all healthy and trending the right way. The one blemish is that returns on the growing invested-capital base are not improving — and ticked down in 2025. Economics improve with scale operationally but not yet on capital, which is the crux of the skeptical case.

7. Capital Allocation

The model: a programmatic M&A compounder. CRH has completed well over a thousand acquisitions in its history and runs at ~38–40 deals and ~$3–5bn of M&A per year — overwhelmingly bolt-on/tuck-in (densifying existing local positions, which extends the moat and drives synergies) with occasional ~$2bn platform deals (Hunter cement 2024; Eco Material 2025). This is, on the evidence, disciplined and value-accretive: gross margin has risen 300bps and EBITDA margin 640bps over five years partly because acquisitions are integrated into a denser, higher-utilization network. Management claims it typically reduces the effective entry multiple by 2–2.5x via synergies (e.g., the Hunter plant “delivered synergies well ahead of expectations”) — credible directionally but not independently verifiable from filings (treat as hypothesis).

Shareholder returns. CRH reduced its share count from 785.1m (2020) to 668.6m (2025) — a ~15% reduction — via consistent buybacks ($1.2–3.1bn/year), and it grows its dividend steadily ($1.48/share in 2025, +6%; ~26% payout, with the Q1 2026 quarterly dividend raised another 5% to $0.39). The buyback is ongoing in $0.3bn tranches. Total capital returns are meaningful but secondary to M&A in the priority stack — appropriate for a business with a long runway of accretive consolidation, provided the deals keep earning their cost of capital.

Incentive alignment. The compensation structure is reasonably well-designed for an M&A roll-up: the annual bonus is driven by diluted EPS, cash flow, and RONA (return on net assets); the long-term plan adds relative TSR and a sustainability modifier. RONA and relative TSR are the right anchors — they discourage value-destructive empire-building and reward returns, not just size. The caveat: RONA is an internal net-assets measure, not an explicit ROIC-versus-WACC hurdle, and EPS rewards buyback-driven accretion. CEO Mintern’s 2025 total comp stepped up to $17.8m (from $5.7m) on his promotion — now in line with US large-cap norms post-NYSE-listing. Say-on-pay passed with 94.6% support.

Insider behavior. Neutral-to-slightly-positive. The Form 4 corpus shows only three open-market purchases (all directors, ~$750k total; the most notable being director Richard Fearon — ex-Eaton CFO — building a 143,800-share stake), no executive open-market buying, and routine vest-and-withhold activity plus one modest discretionary COO sale (Randy Lake, 40,000 shares / ~$4.4m in August 2025, retaining 50,224). There is no bearish cluster of executive selling and no strong bullish signal — consistent with a European-heritage company only recently subject to US equity-ownership norms.

The skeptical lens. The one genuine concern is the conjunction of (a) a declining adjusted ROIC (13.4% → 12.1%), (b) a goodwill balance that grew to $13.1bn, and © zero meaningful impairments. Either CRH’s underwriting is genuinely excellent (the bull read, supported by rising margins and a higher ROIC than the pure-plays) or impairment recognition lags reality and returns are being quietly diluted (the bear read). The next several years of ROIC trend will adjudicate.

Verdict: management has allocated capital intelligently — but the returns are now the thing to watch. A multi-decade track record of accretive consolidation, real per-share value creation (share count down 15%, dividend compounding), and returns-aware incentives. The grade is B+/A-, marked down from “A” only by the 2025 ROIC dip and the unverifiable synergy claims.

8. Changes and Headwinds — Last Two Years

Strategic / corporate.

• NYSE primary listing (Sept 2023) and S&P 500 inclusion — the defining structural change; drove the re-rating. The LSE delisting is now in progress to make CRH solely NYSE-listed, completing the redomicile.
• Leadership transition: Albert Manifold (CEO 2014–2024) handed to Jim Mintern on 1 January 2025; Nancy Buese became CFO in May 2025 (a US-credentialed financial executive, ex-Newmont/MPLX). New director additions and an auditor change in 2025. A material leadership turnover to digest, though continuity of strategy is high (Mintern was the prior CFO).

M&A and portfolio (the continuous activity).

• 2024: 40 acquisitions (~$5.0bn), led by the ~$2.1bn Texas cement/ready-mix (Hunter) portfolio and the Adbri majority stake in Australia; European Lime divested.
• 2025: 38 acquisitions (~$4.1bn), led by Eco Material ($2.1bn, fly-ash/SCM).
• 2026 YTD: Axius Water ($700m) plus 8 other deals (~$900m total), and ~$1.9bn of divestitures (Construction Accessories, Lawn & Garden, MoistureShield) — recycling non-core capital into higher-growth water and connected platforms.

Operating / financial.

• Continued margin expansion (+70bps in Q1 2026; +200bps in International in 2025).
• Net debt rose to ~$14.2bn (from ~$5.4bn in 2023) as M&A accelerated — leverage still modest at ~1.8x but the trend bears watching.
• 2026 guidance reaffirmed in Q1: adjusted EBITDA $8.1–8.5bn, net income $3.9–4.1bn, diluted EPS $5.60–6.05.

Headwinds.

1. The September 2026 IIJA reauthorization cliff — the dominant macro overhang; a hard cliff or a short-term continuing resolution (versus a multi-year step-up) would cap the infrastructure tailwind.
2. Soft US residential new-build — affordability-driven; caps one demand leg (partly offset by resilient R&R).
3. Energy-cost volatility — cement is energy-intensive; energy is ~5% of revenue, hedged ~9 months rolling, so manageable but a margin swing factor.
4. European cement carbon costs — EU ETS (>$80/t) and CBAM (from 2026); material for the minority European cement business, immaterial for the ~75% NA operations.
5. Valuation/expectations risk — the stock corrected ~25–28% from its late-2025 peak as the market shifted to “show-me”; the re-rating cushion is gone.

Verdict: net neutral-to-slightly-positive on the thesis, with elevated execution scrutiny. The structural changes (listing completion, water platform, continued accretive M&A) strengthen the long-term story; the leadership turnover and the macro/valuation headwinds raise the bar on near-term execution. Nothing here breaks the thesis; everything raises the importance of the ROIC trend and the IIJA outcome.

9. Risk Analysis (Risk Matrix)

Aggregate read: The risk profile is cyclical/macro and capital-efficiency, not structural or existential. The moat is not at risk; the asset base is not at risk; the balance sheet is sound. The risks that matter are (1) the IIJA cliff, (2) the cycle, and (3) whether M&A keeps earning its cost of capital. The chance of catastrophic permanent loss is very low.

10. Valuation Discussion (Embedded Expectations)

No price target and norecommendation in this section. The analysis frames what the current price implies.

Where the multiple sits. At $106.48, with ~668m shares (~$71bn market cap), $14.2bn net debt and $1.5bn minority interest, CRH’s enterprise value is ~$87bn. Against FY2025 adjusted EBITDA of $7.7bn that is ~11.3x trailing; against the 2026 guide midpoint (~$8.3bn) it is ~10.4x forward EV/EBITDA. On earnings, trailing P/E is ~19.3x ($5.51 EPS) and forward P/E ~18.3x (2026 EPS midpoint $5.83). Price/book is ~2.8–3.0x; price/tangible book ~7x (goodwill-heavy).

The peer comp table (the frame the bulls live in).

The tension is stark in one line: CRH earns a higher ROIC than either pure-play, yet trades at roughly half their EV/EBITDA. The bull says that gap is absurd for the larger, higher-returning, more-diversified global #1. The bear says the gap is the market correctly penalizing a ~20% blended margin versus ~29–34% pure-aggregates margins — investors pay up for the purity of VMC/MLM’s exposure to the single best node, not for size or even ROIC. The truth is in between: a discount is warranted, but a ~40% discount likely overstates it.

Two reference frames, two conclusions.

1. Versus its own history: full. CRH sits at the 87th percentile of its ten-year valuation range (91st on P/B, 93rd on P/S; the P/E percentile, 77th, is less extreme). The P/E has gone from 7x (2022) to ~19x; EV/EBIT from 9x to ~17x. This is a stock at the richest absolute valuation it has ever carried. But — critically — that re-rating is structural (a one-time shift from a European conglomerate discount to a US-industrial multiple via the NYSE listing and index inclusion), so the percentile overstates how “expensive” the stock is relative to fair value. The right read is “fairly-to-fully valued on its own history,” not “bubble.”
2. Versus US pure-play peers: cheap, but partly deservedly. CRH’s ~10.4x forward EV/EBITDA compares to ~18.5x (VMC) and ~20.7x (MLM) — a ~40–45% discount. Roughly half of that gap is justified by CRH’s lower blended margin (~20% vs ~29–34%) and more-diversified, more-international, more-cement-and-downstream mix; the other half is the residual “is a global #1 with a higher ROIC really worth half the multiple of its smaller pure-play peers?” mispricing the bulls point to.

Embedded-expectations math. At ~10.4x forward EBITDA for a business that has compounded EBITDA at a mid-teens rate and guides to ~8–10% EBITDA growth in 2026, the market is underwriting continued high-single-digit EBITDA growth, successful capital deployment at roughly the current ~10–12% ROIC, and no permanent impairment of the infrastructure tailwind. That is not a demanding hurdle versus peers, and it is achievable if IIJA reauthorizes and the resi cycle stabilizes. It is a hurdle that leaves little margin for error: with the multiple-expansion lever spent, a growth disappointment (a hard IIJA cliff, a recession, or continued ROIC erosion) would compress both earnings and the multiple simultaneously.

Scenario sketch (illustrative, not a target).

• Bear: IIJA hard cliff / recession; 2027 EBITDA flat-to-down, ROIC slips below 10%, multiple de-rates toward 8–9x → meaningful downside.
• Base: IIJA extends/reauthorizes modestly, resi stabilizes; EBITDA grows high-single-digits to ~$8.3–9.0bn, ROIC holds ~12%, multiple steady ~10–11x → returns roughly track EBITDA growth plus the ~1.5% dividend and buyback.
• Bull: Multi-year IIJA step-up + data-center boom + ROIC re-accelerates above 13%; EBITDA toward ~$9.5bn+ and partial further re-rate toward peers → attractive upside.

Verdict: Fairly valued. The market is pricing CRH as a quality compounder that will execute — neither as a bargain (it isn’t, on its own history) nor as priced for perfection (it trades at a large, partly-justified discount to peers). The embedded expectations are reasonable, not stretched; the risk is asymmetric to the downside only insofar as the multiple cushion is gone.

11. Variant Perception

Consensus view. CRH is a high-quality, US-centric building-materials compounder and a prime IIJA/reindustrialization beneficiary; the NYSE re-rating has been earned; it remains “cheap versus VMC/MLM” with further re-rating upside, and the M&A machine reliably compounds value. Sell-side is broadly constructive.

The strongest bull case. The moat is genuinely elite (deepest US reserves, broken capital-cycle mean-reversion), CRH earns a higher ROIC than the pure-plays yet trades at half their multiple, ~half the IIJA construction money is still to come, the water platform opens a large new fragmented runway, and a multi-decade capital-allocation machine keeps converting bolt-ons into margin expansion and per-share growth. If the peer discount even partially closes while EBITDA compounds, the stock works well from here.

The strongest bear case. The re-rating is over — the stock sits at its richest-ever own valuation, the peer discount is largely deserved by mix, and the quality of the compounding is quietly deteriorating: adjusted ROIC fell 130bps in 2025 on a $13.1bn goodwill base with no impairments, suggesting the M&A pace is outrunning returns. Layer on a high-beta cyclical (−15% in six months) heading into the September-2026 IIJA cliff with soft residential new-build, and you have a fully-valued cyclical with the multiple cushion spent and the marginal returns thinning. “Show-me” is the correct posture.

The 3–5 assumptions that matter most:

1. IIJA reauthorization — multi-year step-up (bull) vs. hard cliff / short CR (bear). The dominant volume swing factor. Falsification: watch the H2-2026 Congressional outcome; a multi-year bill with a funding fix confirms the bull, a lapse/CR confirms the bear.
2. ROIC trajectory — re-accelerates above 13% (M&A genuinely accretive) vs. continues below 11% (deals diluting returns). Falsification: the FY2026/2027 adjusted-ROIC disclosure.
3. The peer discount — closeable mispricing vs. deserved mix penalty. Falsification: whether CRH’s blended margin converges toward pure-play levels or stays ~10pts below.
4. Pricing power persistence — mid-single-digit aggregates pricing holds through a soft volume patch (confirms moat) vs. price gives back (breaks the thesis). Falsification: quarterly mix-adjusted aggregates pricing.
5. Residential recovery timing — affordability eases / rates fall (upside) vs. prolonged new-build weakness (caps a leg).

Factor-positioning read (where consensus may be offsides). The tape says the crowd has already shifted from “re-rating winner” to “show-me”: CRH is a high-beta (~1.3), quality- and dividend-tilted name whose positive momentum rolled over into a 28% six-month drawdown even as three-year returns stayed strong (+32%/yr). This is not a falling knife (a three-month bounce, quality and dividend support) but a crowded compounder that de-rated on cyclical/macro fear. The variant-perception opportunity, if there is one, is that the market has over-extrapolated the IIJA-cliff and resi worries into a high-quality asset whose pricing power is intact — but that is only a buy-the-fear opportunity at a lower price (sub-$95–100), because at $106 the valuation already reflects neither panic nor euphoria.

My variant take: The consensus “still cheap vs peers, keep re-rating” is half-right and half-stale. The genuine variant perception is that the quality of the compounding (ROIC), not the multiple, is the real debate — and the market is under-focused on the 2025 ROIC dip. If ROIC stabilizes/re-accelerates, CRH is a fine compounder at a fair price; if it keeps slipping, the peer discount is permanent and deserved. That, not “will the discount close,” is the question that determines the next five years.

12. Fact vs. Interpretation Table

13. Open Questions

1. IIJA reauthorization: multi-year step-up, short-term extension, or hard cliff after 30 September 2026? Resolves the dominant volume variable.
2. ROIC trend: does adjusted ROIC stabilize/re-accelerate above 13%, or keep slipping toward/below 10%? The single most important quality metric to track.
3. Maintenance vs. growth capex split — not disclosed in the 10-K; needed to assess true owner-earnings and the real return on growth capital.
4. Synergy verification: are the claimed “2–2.5x entry-multiple reduction” synergies real and durable, or partly accounting/normalization? Watch for any future goodwill impairments as the tell.
5. Water platform returns: does Axius/water earn aggregates-like returns, or dilute group ROIC as a lower-margin services adjacency?
6. Peer-discount resolution: does CRH’s blended margin converge toward pure-play levels (closeable gap) or stay ~10 points below (deserved discount)?
7. Leadership execution: can the new Mintern/Buese team sustain the Manifold-era cadence and discipline?

14. What Must Be True (Bull and Bear, with Falsification Tests)

For the BULL case to be right, the following must be true:

• Aggregates pricing power persists through any volume softness (mid-single-digit pricing holds). Falsification test: two-plus consecutive quarters of flat or negative mix-adjusted aggregates pricing would break the core moat assumption.
• M&A keeps earning its cost of capital — adjusted ROIC stabilizes/re-accelerates (≥13%) rather than continuing to decline. Falsification test: a further ROIC decline in FY2026 (toward or below 11%), or any material goodwill impairment, falsifies the “accretive compounder” claim.
• The infrastructure tailwind continues — IIJA reauthorizes (multi-year) or extends, keeping public-infra volumes growing. Falsification test: a funding lapse / short-term-only CR with declining obligations into 2027.
• Some of the peer discount is genuinely closeable — the market re-rates CRH’s higher-ROIC, larger-scale franchise toward (not to) peer multiples. Falsification test: the EV/EBITDA gap to VMC/MLM widens despite in-line execution.

For the BEAR case to be right, the following must be true:

• The re-rating is fully spent and partly reverses — at the 87th valuation percentile with the multiple cushion gone, any disappointment compresses both E and the multiple. Falsification test: the stock re-rates higher (toward peers) on continued execution, proving residual upside in the multiple.
• The compounding quality is deteriorating — ROIC keeps slipping as goodwill-heavy M&A outruns returns, eventually forcing impairments. Falsification test: adjusted ROIC re-accelerates above 13% with no impairments — proving the deals are accretive.
• The cycle/macro bites — IIJA cliff and/or recession depress volumes, exposing a high-beta cyclical at a full multiple. Falsification test: volumes and backlogs keep growing through 2026–27 on a reauthorized bill and data-center demand.

Synthesis: The bull and bear cases hinge on the same two variables — the IIJA reauthorization outcome and the ROIC trajectory. CRH is a genuinely high-quality business at a fair price; whether it is a good investment from $106 depends almost entirely on those two falsifiable questions resolving favorably. That is why the honest stance is “watch the ROIC and the reauthorization,” not a directional bet at today’s price.

15. Source Appendix

See the full Source Appendix (Appendix B) below for the complete, dated source list. Primary sources: CRH plc FY2025 Form 10-K (CIK 0000849395), FY2023/FY2024 10-Ks, DEF 14A (27-Mar-2026), Form 4 filings, 8-K filings; Q1 2026 earnings call transcript (30-Apr-2026); CRH Q4/FY2025 results release (BusinessWire, 18-Feb-2026). Quantitative cross-checks: public aggregated financial data (statements, ratios, enterprise value, multiples — CRH/VMC/MLM), own-history valuation percentiles, and a public factor model (factor loadings, risk-adjusted track record). Industry/regulatory: ASCE 2025 Infrastructure Report Card, Congress.gov CRS R47573 (surface transportation reauthorization), US Census construction data, ConstructConnect forecasts, ICAP (EU ETS/CBAM).

APPENDIX A — Standard Diligence Questionnaire

CRH plc (NYSE: CRH) — Standard Diligence Questionnaire

Supplemental to the main analysis. Fact/Interpretation/Assumption labeled where it matters.

General

What thoughtful questions have other investors asked about this company? The recurring debates: (1) Is CRH still cheap versus Vulcan/Martin Marietta, or is the discount now deserved by its lower-margin, more-diversified mix? (2) Has the NYSE re-rating run its course? (3) Is the M&A machine still creating value, given the 2025 dip in adjusted ROIC (13.4%→12.1%) on a $13.1bn goodwill base with no impairments? (4) How exposed is CRH to the September-2026 IIJA reauthorization cliff? (5) Can the new CEO/CFO (Mintern/Buese, both 2025) sustain the Manifold-era compounding cadence? (Interpretation, from the bull/bear framing.)

Cyclicality & Earnings Nature

Are earnings at a cyclical high or low? Mid-cycle, tilted toward the high side on margins/multiple but not on volumes. Aggregates pricing is at structurally elevated, still-rising levels (pricing power), and EBITDA margin (20.5%) is at a record — so earnings are not depressed. But volumes are mid-cycle: residential new-build is below trend and IIJA is only ~half-deployed, leaving volume upside. So: margins/price near a high, volumes with room to recover. (Interpretation.)

Driven by the external environment or internal actions? Both. External: IIJA-funded infrastructure, data-center/reindustrialization demand, the construction cycle. Internal: pricing discipline, acquisition synergies, operating-efficiency programs (“CRH Winning Way”) — the +640bps EBITDA-margin expansion since 2020 is substantially self-help, not just cycle. (Interpretation.)

How stable are revenues? More stable than a typical cyclical because ~public infrastructure (the largest end-market) is funded on multi-year programs and aggregates pricing rises through cycles. But revenue is transactional, not contractual/recurring; volumes are cyclical. Revenue grew every year 2020–2025 ($25.9bn→$37.4bn). (Fact + Interpretation.)

Outlook for products/services? Positive. Essential, non-substitutable materials with secular demand from transportation, water, and reindustrialization. The four “growth platforms” (aggregates, cementitious, roads, water) are all in growing markets. (Interpretation.)

How big will this market be — growing, shrinking, domestic or international? Growing. US construction materials demand is supported by IIJA (~half still to spend), record state DOT budgets, data-center/onshoring megaprojects, and a ~$100bn+ annual water-infrastructure ecosystem. ~75% domestic (NA); the rest Europe (sluggish) and Australia (steady). (Fact/Interpretation.)

Business Quality & Competitive Moat

Is the industry getting more or less competitive? Less, at the aggregates node — consolidation (Quikrete/Summit, continuous bolt-ons) is concentrating a permit-constrained supply base, and new supply can’t be built. Cement and downstream are more competitive. (Interpretation.)

How profitable is the business (ROIC, ROE)? ROE ~14.9%; GAAP ROIC ~10%; adjusted ROIC 12.1% (2025). Above an estimated ~8–9% WACC, but the spread is thin and ROIC declined 130bps in 2025 — the central quality question. (Fact + Interpretation.)

How profitable is the industry — competitors, barriers to entry? Aggregates is among the most profitable, highest-barrier industries in industrials: pure-plays VMC/MLM run ~29–34% EBITDA margins; barriers are permitting + reserve scarcity + transport economics (a local monopoly). CRH’s blended margin (~20%) is lower because of cement/downstream/international mix. (Fact.)

Can the business be easily understood? Yes at the unit level (quarries, plants, pricing), harder at the group level given 4,000 locations, ~40 acquisitions/year, and constant portfolio churn. The M&A complexity is the main analytical friction. (Interpretation.)

Can it be undermined by foreign low-cost labor? No. Aggregates and ready-mix are local-by-physics (uneconomic to ship); cement is partly importable but transport-limited. Labor offshoring is irrelevant. (Fact/Interpretation.)

Do brands matter? Minimally. This is a B2B commodity/solutions business; the “brand” that matters is local reserve position, reliability, and integrated capability, not consumer brand. (Interpretation.)

What is the nature of competition? Local oligopoly/monopoly in aggregates (compete on landed cost within a radius); more conventional competition in cement, products and services. CRH competes on scale, reserve depth, vertical integration, and the ability to bid whole infrastructure jobs. (Interpretation.)

Customers’ switching costs? Geographic rather than contractual — a contractor near a CRH quarry has no economic alternative because the next-nearest quarry’s freight cost is prohibitive. A hard, structural lock-in even without contracts. (Interpretation.)

Financial Condition & Balance Sheet

Assets not fully recognized on the balance sheet? Yes — the aggregates reserves (~23.8bn tons) are carried at historical cost and are worth vastly more than book; this is the hidden asset. Conversely, ~$13.1bn goodwill + $2bn intangibles inflate book relative to tangible value (P/TBV ~7x). (Fact/Interpretation.)

Off-balance-sheet liabilities? Operating leases (~$1.5bn, not in the headline net-debt figure), routine reclamation/restoration obligations for quarries, and pension ($248m, small). No unusual hidden leverage. (Fact.)

How conservative is the accounting? Reasonable. The QoE flags: 2022 net income flattered by a $1.19bn discontinued-ops gain (OBE divestiture); recurring lumpy disposal gains; and — the watch item — no goodwill impairments despite an aggressive deal pace and declining ROIC. Not aggressive, but the impairment-recognition lag is worth monitoring. (Interpretation.)

How CapEx-hungry is the business? Capital-intensive: ~$2.7bn/year capex (~7% of revenue), plus ~$3–5bn/year of acquisitions. This is a heavy business; the offset is the deep, depleting-slowly reserve base and high cash conversion (CFO ~1.5x net income). (Fact.)

Capital Allocation & Management

How much FCF does the business generate, and how is it used? ~$2.9bn simple FCF (CFO $5.6bn − capex $2.7bn) in 2025. Priority stack: (1) bolt-on M&A (~$3–5bn/year, the dominant use), (2) dividends (~$1.0bn, growing ~5–6%/year), (3) buybacks ($1.2–3.1bn/year). Philosophy: recycle capital into higher-growth connected platforms; “every decision through the lens of maximizing shareholder value.” (Fact + mgmt claim.)

Significant acquisitions recently? Yes — continuously. 2024: ~$5.0bn (Hunter cement $2.1bn, Adbri/Australia). 2025: ~$4.1bn (Eco Material $2.1bn). 2026 YTD: Axius Water $700m + 8 deals. Plus ~$1.9bn of 2026 divestitures (Lawn & Garden, Construction Accessories, MoistureShield). (Fact.)

Buying back shares? Yes — share count down ~15% (785m→669m) since 2020; ongoing $0.3bn tranches. (Fact.)

Issuing large amounts of new shares to insiders? No — SBC is small (~$143m); dilution is immaterial and more than offset by buybacks. (Fact.)

Compensation policy of directors/management? Returns-aware: annual bonus on diluted EPS / cash flow / RONA; LTIP on cash flow / RONA / relative TSR / sustainability. CEO 2025 comp $17.8m (US large-cap norm post-promotion). Say-on-pay 94.6% for. Caveat: RONA is not an explicit ROIC-vs-WACC hurdle. (Fact + Interpretation.)

Motivations of management? Long-tenured, internally-promoted team (Mintern ex-CFO; the culture is a disciplined M&A compounder). Incentives reasonably aligned to per-share returns. New CFO Buese adds US-capital-markets credibility. (Interpretation.)

Valuation & Market Data

Is the stock an ADR, MLP, or K-1 issuer? No K-1/MLP. CRH plc is an Irish-incorporated company with a primary NYSE listing (ordinary shares trading directly; the LSE listing is being wound down). Some data vendors label it “ADR,” but it is a direct ordinary-share listing, not a classic ADR structure. US-dollar reporting, US GAAP. (Fact.)

Dividend policy? Consistent long-term growth; $1.48/share in 2025 (+6%); Q1 2026 quarterly dividend +5% to $0.39; ~26% payout; yield ~1.5%. (Fact.)

How profitable is the business? See above — ~20.5% EBITDA margin, ~10% net margin, ~15% ROE, ~10–12% ROIC. Solidly profitable, improving operationally. (Fact.)

Is net income diverging from cash from operations? No adverse divergence — CFO ($5.6bn) consistently exceeds net income ($3.75bn) by ~1.5x, reflecting heavy D&A. Healthy cash conversion. (Fact.)

Risks & Downside

What factors would cause the stock to decline? A hard IIJA reauthorization cliff/short CR; a construction recession (high beta ~1.3); continued ROIC erosion / an eventual goodwill impairment signaling M&A overpayment; a valuation de-rating from the 87th-percentile starting point; prolonged residential weakness. (Interpretation.)

Risk of a catastrophic loss? Very low. Hard-asset, diversified, investment-grade (~1.8x leverage), essential-products business with the deepest reserves in the industry. (Interpretation.)

Chance of a total loss? Negligible absent gross mismanagement or a catastrophic debt-funded M&A blunder — neither evident. (Interpretation.)

Recent News & Events

Has the business environment changed recently? Yes: (1) leadership transition (Mintern CEO Jan-2025, Buese CFO May-2025); (2) the stock corrected ~25–28% from its late-2025 peak as the market turned “show-me” ahead of the IIJA cliff; (3) accelerating water-platform build-out (Axius $700m). The AZI curated news feed returned no material CRH-specific items in the window (feed sparse for this name) — the recent-events read is built from the 10-K, Q1-2026 transcript, and 8-K corpus. (Fact.)

Significant acquisitions? Eco Material ($2.1bn, 2025), Axius Water ($700m, 2026), plus continuous bolt-ons — see above. (Fact.)

Change in accounting policies? Transition to US domestic filer / US GAAP reporting completed; auditor change in 2025. No adverse policy changes noted. (Fact.)

Recent changes — new markets, facilities, management? New management team (2025); LSE delisting to NYSE-only; expansion into US water treatment (up the value chain via Axius); continued Australian build-out (Adbri). (Fact.)

APPENDIX B — Source Appendix

CRH plc (NYSE: CRH) — Source Appendix

Accessed 2026-06-14 unless noted. Primary sources first; aggregated/third-party quantitative sources reconciled to filings.

Primary — SEC filings (CIK 0000849395)

1. CRH plc FY2025 Form 10-K (period ended 31-Dec-2025; filed ~18-Feb-2026) — income statement, balance sheet, cash flow, segment data, mineral reserves, net-debt reconciliation, adjusted ROIC, M&A development review.
2. CRH plc FY2023 / FY2024 Form 10-K — comparatives; 2022 continuing-vs-discontinued operations (Oldcastle BuildingEnvelope gain).
3. CRH plc DEF 14A proxy statement (filed 27-Mar-2026) — executive compensation, incentive metrics (EPS/Cash Flow/RONA/relative TSR), board composition, CEO/CFO transition, say-on-pay.
4. CRH plc Form 4 corpus (67 filings) — insider transactions; three director open-market purchases; vest-and-withhold activity; COO discretionary sale.
5. CRH plc 8-K corpus (46 filings) — M&A announcements (Eco Material, Hunter, Adbri, Axius), debt offerings, leadership/board changes, auditor change, earnings releases, buyback notifications.
6. Pre-2024 20-F / 6-K filings (foreign-private-issuer era) — historical context.

Primary — company communications

7. CRH Q1 2026 earnings call transcript (30-Apr-2026) — Jim Mintern (CEO), Nancy Buese (CFO), Randy Lake (COO); FY2026 guidance (adj EBITDA $8.1–8.5bn, net income $3.9–4.1bn, diluted EPS $5.60–6.05), Q1 results, portfolio activity, IIJA commentary, energy hedging, winter-fill.
8. CRH Q4 & FY2025 results release — BusinessWire, 18-Feb-2026: https://www.businesswire.com/news/home/20260218871394/en/CRH-Reports-Q4-and-FY-2025-Results (aggregates volumes/pricing, ~23.8bn tons reserves, adjusted EBITDA).
9. CRH Investor Day (Sept 2024) materials — four growth platforms framing (referenced via transcript/IR).
10. CRH corporate / water-infrastructure thought-leadership: https://www.crh.com/media/crisis-opportunity-or-both-reinventing-us-water-infrastructure/ ; VODA.ai partnership: https://www.crh.com/news-and-insights/innovation/crh-invests-in-ai-driven-technology-to-make-the-invisible-visible/

Quantitative cross-checks (third-party aggregated; reconciled to filings)

11. Public aggregated financial data — CRH/VMC/MLM income statement, balance sheet, cash flow, profitability ratios, enterprise value, valuation multiples (annual, multi-year). Note: some aggregators report CRH’s “EBITDA” as operating income (EBIT); true EBITDA computed with the D&A add-back.
12. Own-history valuation percentiles — composite 87th; P/E 77th, P/B 91st, P/S 93rd (price $106.48 as of 2026-06-12); daily price/OHLCV + moving averages.
13. Public factor model (factorstoday.com) — factor loadings (Market +1.34, Quality +0.19, DividendYield +0.10, Momentum +0.08; r² 0.61) and risk-adjusted track record (3yr +31.6%/Sharpe 0.97; 6mo −15% (−28.6% ann.)).

Peer / competitor data

14. Vulcan Materials (VMC) and Martin Marietta (MLM) — Public aggregated enterprise value and multiples (TTM EV/EBITDA ~18.5x / ~20.7x; margins ~29% / ~34%; reserves ~16.6bn / ~16.8bn tons). VMC 10-K (StockTitan), MLM IR.
15. Holcim → Amrize spin — Amrize Form 8-K / SEC filing (NYSE: AMRZ, distribution 23-Jun-2025): https://www.sec.gov/Archives/edgar/data/0002035989/000114036125023352/ef20050735_ex99-1.htm
16. Heidelberg Materials record 2025 results — CemNet: https://www.cemnet.com/News/story/180870/
17. Quikrete / Summit Materials acquisition (~$11.5bn, Feb-2025) — Pit & Quarry: https://www.pitandquarry.com/done-deal-quikrete-acquires-summit-for-11-5b/

Industry / regulatory

18. Aggregates transport economics & permitting — Rock Products: https://rockproducts.com/2025/01/03/the-2024-regional-pricing-puzzle/ ; https://rockproducts.com/2025/12/02/should-sales-set-prices-in-aggregates/ ; Highways.today: https://highways.today/2025/12/31/quarries-aggregates-infrastructure/ ; Pit & Quarry aggregates pricing.
19. IIJA funding/deployment — Funding Landscape: https://fundinglandscape.com/answers/infrastructure-iija-funding-2026 ; reauthorization & HTF gap — Congress.gov CRS R47573: https://www.congress.gov/crs-product/R47573 ; Bipartisan Policy Center: https://bipartisanpolicy.org/explainer/how-iijas-funding-structure-complicates-surface-transportation-reauthorization/ ; IIJA expiry — Grit Insurance: https://gritinsurance.com/blog/iija-infrastructure-act-expires-september-2026
20. US water infrastructure — ASCE 2025 Infrastructure Report Card; EPA DWSRF/lead-pipe (WaterWorld): https://www.waterworld.com/drinking-water-treatment/distribution/news/55379259/ ; Axius Water deal — Bluefield Research: https://www.bluefieldresearch.com/research/crh-moves-along-value-chain-with-us700-million-axius-water-acquisition/
21. US construction outlook — US Census new residential construction: https://www.census.gov/construction/nrc/pdf/newresconst.pdf ; ConstructConnect forecasts (Spring/Summer 2026).
22. EU carbon / CBAM — ICAP: https://icapcarbonaction.com/en/news/eu-carbon-border-adjustment-mechanism-cbam-takes-effect-transitional-phase

Analytical frameworks

23. Competition Demystified (Greenwald & Kahn) — moat taxonomy (cost/supply advantage + local scale + captivity). Capital Returns (Marathon/Chancellor) — capital-cycle / broken-mean-reversion lens.